Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
Google ScholarÂ
Zhang, Y. et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N. Engl. J. Med. 381, 1124–1135 (2019).
Google ScholarÂ
Zhang, Y. et al. Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: a multicenter, randomized phase III trial. J. Clin. Oncol. 40, 2420–2425 (2022).
Google ScholarÂ
Tang, L. L. et al. CACA guidelines for holistic integrative management of nasopharyngeal carcinoma. Holist. Integr. Oncol. 2, 24 (2023).
Google ScholarÂ
Caudell, J. J. et al. NCCN Guidelines® Insights: head and neck cancers, version 1.2022. J. Natl Compr. Canc. Netw. 20, 224–234 (2022).
Google ScholarÂ
Liu, S. L. et al. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial. Lancet. Oncol. 25, 1563–1575 (2024).
Google ScholarÂ
Liu, X. et al. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet 403, 2720–2731 (2024).
Google ScholarÂ
Liang, Y. L. et al. Adjuvant PD-1 blockade with camrelizumab for nasopharyngeal carcinoma: the DIPPER randomized clinical trial. JAMA 333, 1589–1598 (2025).
Google ScholarÂ
Wong, K. et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat. Rev. Clin. Oncol. 18, 679–695 (2021).
Google ScholarÂ
Lee, V. H. et al. International recommendations for plasma Epstein–Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic. Lancet Oncol. 23, e544–e551 (2022).
Google ScholarÂ
Yang, Y. et al. Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: a multicenter phase 3 trial (RATIONALE-309). Cancer Cell 41, 1061–1072 (2023).
Google ScholarÂ
Mani, D. R. et al. Cancer proteogenomics: current impact and future prospects. Nat. Rev. Cancer 22, 298–313 (2022).
Google ScholarÂ
Jiang, Y. et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567, 257–261 (2019).
Google ScholarÂ
Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382–387 (2014).
Google ScholarÂ
Lin, D. C. et al. The genomic landscape of nasopharyngeal carcinoma. Nat. Genet. 46, 866–871 (2014).
Google ScholarÂ
Bruce, J. P. et al. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape. Nat. Commun. 12, 4193 (2021).
Google ScholarÂ
Chen, Y. P. et al. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Mol. Cancer 20, 14 (2021).
Google ScholarÂ
Liu, S. L. et al. Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Eur. J. Cancer 163, 26–34 (2022).
Google ScholarÂ
Fu, Y. et al. Proteomics profiling reveals the molecular signatures and potential therapeutic targets of human nasopharyngeal carcinoma. Mol. Cell. Proteomics 22, 100567 (2023).
Google ScholarÂ
Chen, C. et al. Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma. J. Transl. Med. 21, 278 (2023).
Google ScholarÂ
Zhang, L. et al. Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes. Mol. Cancer Res. 15, 1722–1732 (2017).
Google ScholarÂ
Lin, W. et al. Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma. Br. J. Cancer 130, 1176–1186 (2024).
Google ScholarÂ
Lei, Y. et al. A gene-expression predictor for efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. J. Natl Cancer Inst. 113, 471–480 (2021).
Google ScholarÂ
Zhai, H. et al. Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma. Ann. Oncol. 31, 169–170 (2020).
Google ScholarÂ
Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696–705 (2018).
Google ScholarÂ
Chen, S., Zhu, H. & Jounaidi, Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal Transduct. Target. Ther. 9, 302 (2024).
Google ScholarÂ
Shen, J. et al. Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth. Nat. Immunol. 26, 416–428 (2025).
Google ScholarÂ
Boulch, M. et al. Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity. Nat. Cancer 4, 968–983 (2023).
Google ScholarÂ
Gocher, A. M. et al. Interferon-γ: teammate or opponent in the tumour microenvironment? Nat. Rev. Immunol. 22, 158–172 (2022).
Google ScholarÂ
de Sousa-Pereira, P. & Woof, J. M. IgA: structure, function, and developability. Antibodies 8, 57 (2019).
Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94–98 (2015).
Google ScholarÂ
Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340–345 (2017).
Google ScholarÂ
Cerutti, A. The regulation of IgA class switching. Nat. Rev. Immunol. 8, 421–434 (2008).
Google ScholarÂ
Mauri, C. et al. The expanding family of regulatory B cells. Int. Immunol. 27, 479–486 (2015).
Google ScholarÂ
Hu, H. et al. Models for predicting IKKA and IKKB blockade. J. Chem. Inf. Model. 52, 3190–3199 (2012).
Google ScholarÂ
Takeuchi, S. et al. NFKBIA deletion in glioblastomas. N. Engl. J. Med. 365, 276–278 (2011).
Google ScholarÂ
Flavell, R. A. et al. The polarization of immune cells in the tumour environment by TGFβ. Nat. Rev. Immunol. 10, 554–567 (2010).
Google ScholarÂ
Laudisi, F. et al. TGF-β1 signaling and Smad7 control T-cell responses in health and immune-mediated disorders. Eur. J. Immunol. 53, e2350460 (2023).
Google ScholarÂ
Qian, J. et al. A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis. Cancer Cell 43, 1512–1529 (2025).
Google ScholarÂ
Arpinati, L., Carradori, G. & Scherz-Shouval, R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat. Rev. Cancer 24, 676–693 (2024).
Google ScholarÂ
Allard, B., Allard, D., Buisseret, L. & Stagg, J. The adenosine pathway in immuno-oncology. Nat. Rev. Clin. Oncol. 17, 611–629 (2020).
Google ScholarÂ
Bayerl, F. et al. Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses. Immunity 56, 1341–1358 (2023).
Google ScholarÂ
Xu, J. et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct. Target. Ther. 10, 268 (2025).
Google ScholarÂ
Argelaguet, R. et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 21, 111 (2020).
Google ScholarÂ
Lv, J. et al. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nat. Med. 29, 1424–1436 (2023).
Google ScholarÂ
Liu, Y. et al. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Nat. Commun. 15, 7713 (2024).
Google ScholarÂ
Teillaud, J. L. et al. Tertiary lymphoid structures in anticancer immunity. Nat. Rev. Cancer 24, 629–646 (2024).
Google ScholarÂ
Lin, M. et al. Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance. Nat. Commun. 14, 610 (2023).
Google ScholarÂ
Rodriguez, H., Zenklusen, J. C., Staudt, L. M., Doroshow, J. H. & Lowy, D. R. The next horizon in precision oncology: proteogenomics to inform cancer diagnosis and treatment. Cell 184, 1661–1670 (2021).
Google ScholarÂ
Shao, X. et al. ZASP: a highly compatible and sensitive ZnCl2 precipitation-assisted sample preparation method for proteomic analysis. Mol. Cell. Proteomics 23, 100837 (2024).
Google ScholarÂ
Lv, J. et al. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: the EP-SEASON study. Cancer Cell 42, 1401–1414 (2024).
Google ScholarÂ
Young, L. S. & Dawson, C. W. Epstein–Barr virus and nasopharyngeal carcinoma. Chin. J. Cancer 33, 581–590 (2014).
Google ScholarÂ
Chowdhury, S. et al. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell 187, 1016 (2024).
Google ScholarÂ
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Google ScholarÂ
Rappsilber, J. et al. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896–1906 (2007).
Google ScholarÂ
Ochoa, D. et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365–373 (2020).
Google ScholarÂ
Huang, Y. et al. RUPE-phospho: rapid ultrasound-assisted peptide-identification-enhanced phosphoproteomics workflow for microscale samples. Anal. Chem. 95, 17974–17980 (2023).
Google ScholarÂ
Wu, T. et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
Google ScholarÂ
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 102, 15545–15550 (2005).
Google ScholarÂ
Li, J. et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell 41, 1152–1169 (2023).
Google ScholarÂ
Aran, D. et al. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).
Google ScholarÂ
Liu, Z. et al. Multimodal fusion of radio-pathology and proteogenomics identify integrated glioma subtypes with prognostic and therapeutic opportunities. Nat. Commun. 16, 3510 (2025).
Google ScholarÂ
Liu, Z. et al. Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma. Cancer Cell 41, 181–195 (2023).
Google ScholarÂ
Newman, M. E. & Girvan, M. Finding and evaluating community structure in networks. Phys. Rev. E 69, 26113 (2004).
Google ScholarÂ
Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293–304 (2024).
Google ScholarÂ
Jin, S. et al. Inference and analysis of cell–cell communication using CellChat. Nat. Commun. 12, 1088 (2021).
Google ScholarÂ
Ru, B., Huang, J., Zhang, Y., Aldape, K. & Jiang, P. Estimation of cell lineages in tumors from spatial transcriptomics data. Nat. Commun. 14, 568 (2023).
Google ScholarÂ
Liu, Q., Hsu, C. Y. & Shyr, Y. Scalable and model-free detection of spatial patterns and colocalization. Genome Res. 32, 1736–1745 (2022).
Google ScholarÂ
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
Google ScholarÂ
